SCM
SOPH icon

Soleus Capital Management’s SOPHiA GENETICS SOPH Stock Holding History

Soleus Capital Management’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.16M Buy
+1,850,000
New +$9M 0.37% 54

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $14.2B AUM 20.68% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $308M AUM 27.87% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Soleus Capital Management's SOPH Position: Q1 2026 in Review

Soleus Capital Management opened a new position in SOPHiA GENETICS (SOPH) in Q1 2026: 1,850,000 shares worth $9.16M. The stake represents 0.37% of the portfolio and ranks #54 among its holdings.

49 funds tracked by Wall St. Rank hold SOPH as of Q1 2026.

  • Soleus Capital Management held 1,850,000 shares of SOPHiA GENETICS worth $9.16M as of Q1 2026.
  • SOPHiA GENETICS was a new Soleus Capital Management position in Q1 2026.
  • SOPHiA GENETICS made up 0.37% of Soleus Capital Management's portfolio in Q1 2026, its #54 holding.
  • 49 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2026.

Based on Soleus Capital Management's 13F filing for Q1 2026, filed 14 May 2026.